Literature DB >> 8879223

Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients.

I B McInnes1, B P Leung, M Field, X Q Wei, F P Huang, R D Sturrock, A Kinninmonth, J Weidner, R Mumford, F Y Liew.   

Abstract

We have demonstrated spontaneous nitric oxide (NO) production by primary synovial cultures from rheumatoid (RA) and osteoarthritis patients. Increased NO production followed addition of staphylococcal enterotoxin B. Immunochemical double staining with specific anti-human inducible NO synthase (iNOS) and nonspecific esterase (NSE), or anti-CD68 (markers for tissue macrophages) showed that although many lining layer cells in RA synovium expressed iNOS, most (approximately 90%) were NSE- and CD68-, with only a minor population (approximately 10%) which were iNOS+, CD68+/NSE+. These data demonstrate the capacity for high output of NO by human synovial tissue and show that, although human macrophages can express high levels of iNOS, the majority of cells expressing iNOS are fibroblasts. We also report that synoviocytes, and macrophage cell lines, cultured with the NO donor, S-nitroso-acetyl penicillamine, produced high concentrations of tumor necrosis factor (TNF)-alpha. These results suggest that NO may mediate pathology in RA through the induction of TNF-alpha production.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8879223      PMCID: PMC2192822          DOI: 10.1084/jem.184.4.1519

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  28 in total

Review 1.  The L-arginine-nitric oxide pathway.

Authors:  S Moncada; A Higgs
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

2.  Nonspecific acid esterase activity: a criterion for differentiation of T and B lymphocytes in mouse lymph nodes.

Authors:  J Mueller; G Brun del Re; H Buerki; H U Keller; M W Hess; H Cottier
Journal:  Eur J Immunol       Date:  1975-04       Impact factor: 5.532

Review 3.  Role of cytokines in rheumatoid arthritis.

Authors:  M Feldmann; F M Brennan; R N Maini
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

4.  Transcriptional activation of IL-1 beta and tumor necrosis factor-alpha genes by MHC class II ligands.

Authors:  N S Trede; R S Geha; T Chatila
Journal:  J Immunol       Date:  1991-04-01       Impact factor: 5.422

Review 5.  The staphylococcal enterotoxins and their relatives.

Authors:  P Marrack; J Kappler
Journal:  Science       Date:  1990-05-11       Impact factor: 47.728

6.  Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis.

Authors:  F M Brennan; D Chantry; A Jackson; R Maini; M Feldmann
Journal:  Lancet       Date:  1989-07-29       Impact factor: 79.321

7.  Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes.

Authors:  M Schneemann; G Schoedon; S Hofer; N Blau; L Guerrero; A Schaffner
Journal:  J Infect Dis       Date:  1993-06       Impact factor: 5.226

8.  Modulation of human T cell responses by nitric oxide and its derivative, S-nitrosoglutathione.

Authors:  P F Merryman; R M Clancy; X Y He; S B Abramson
Journal:  Arthritis Rheum       Date:  1993-10

9.  Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases.

Authors:  A J Farrell; D R Blake; R M Palmer; S Moncada
Journal:  Ann Rheum Dis       Date:  1992-11       Impact factor: 19.103

10.  Suppression of arthritis by an inhibitor of nitric oxide synthase.

Authors:  N McCartney-Francis; J B Allen; D E Mizel; J E Albina; Q W Xie; C F Nathan; S M Wahl
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

View more
  68 in total

Review 1.  Nitric oxide and bone.

Authors:  R J van't Hof; S H Ralston
Journal:  Immunology       Date:  2001-07       Impact factor: 7.397

Review 2.  Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis.

Authors:  Paul I Mapp; David A Walsh
Journal:  Nat Rev Rheumatol       Date:  2012-05-29       Impact factor: 20.543

3.  In vivo anti-inflammatory activities of the essential oil from Radix Angelicae dahuricae.

Authors:  Chunmei Wang; Jingbo Sun; He Li; Xue Yang; Huimin Liu; Jianguang Chen
Journal:  J Nat Med       Date:  2016-02-23       Impact factor: 2.343

Review 4.  Inducible nitric oxide synthase in human diseases.

Authors:  K D Kröncke; K Fehsel; V Kolb-Bachofen
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

5.  Angiogenesis in rheumatoid arthritis: implications for future therapeutic strategies.

Authors:  E M Paleolog; R A Fava
Journal:  Springer Semin Immunopathol       Date:  1998

6.  Modulation of virus-induced delayed-type hypersensitivity by plasmid DNA encoding the cytokine interleukin-10.

Authors:  E Manickan; M Daheshia; N Kuklin; S Chun; B T Rouse
Journal:  Immunology       Date:  1998-06       Impact factor: 7.397

7.  Slc11a1 (Nramp-1) gene modulates immune-inflammation genes in macrophages during pristane-induced arthritis in mice.

Authors:  Mara A Correa; Tatiane Canhamero; Andrea Borrego; Iana S S Katz; José R Jensen; José Luiz Guerra; Wafa H K Cabrera; Nancy Starobinas; Jussara G Fernandes; Orlando G Ribeiro; Olga M Ibañez; Marcelo De Franco
Journal:  Inflamm Res       Date:  2017-07-01       Impact factor: 4.575

8.  Down regulation of interleukin 1beta production in human osteoarthritic synovial tissue and cartilage cultures by aminoguanidine.

Authors:  I Shirazi; I Yaron; Y Wollman; M Blum; T Chernihovsky; R Judovich; A Iaina; M Yaron
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

9.  The effects of dithiaden on nitric oxide production by RAW 264.7 cells.

Authors:  Jana Králová; Michaela Pekarová; Katarína Drábiková; Viera Jančinová; Radomír Nosáľ; Milan Cíž; Antonín Lojek
Journal:  Interdiscip Toxicol       Date:  2008-12

10.  Effect of sildenafil citrate on interleukin-1beta-induced nitric oxide synthesis and iNOS expression in SW982 cells.

Authors:  Kyung-Ok Kim; Shin-Young Park; Chang-Woo Han; Hyun Kee Chung; Dae-Hyun Yoo; Dae-Hyun Ryu; Joong-Soo Han
Journal:  Exp Mol Med       Date:  2008-06-30       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.